ÐÂÇàÄêÂé×íÂÛ̳

 ÕÒ»ØÃÜÂë
 »áÔ±×¢²á

QQ怬

Ö»ÐèÒ»²½£¬¿ìËÙ¿ªÊ¼

¿ì½ÝµÇ¼

ËÑË÷
²é¿´: 1313|»Ø¸´: 0
´òÓ¡ ÉÏÒ»Ö÷Ìâ ÏÂÒ»Ö÷Ìâ

[ҽѧָÄÏ] Öé½­ÊÓ½ç | ÿÔºÃÎÄ£º¹úÄÚÂé×íѧ¿ÆÎÄÕª2023.09£¨Ï£©

[¸´ÖÆÁ´½Ó]
Ìø×ªµ½Ö¸¶¨Â¥²ã
1#
·¢±íÓÚ 2023-10-27 02:35:31 | Ö»¿´¸Ã×÷Õß »ØÌû½±Àø |µ¹Ðòä¯ÀÀ |ÔĶÁģʽ
±¾Ìû×îºóÓÉ ÌÇÌDz»´ÎÌÇ ÓÚ 2023-10-27 02:36 ±à¼­


ÒëÕß°´£º

ÄÏ·½Ò½¿Æ´óѧÖé½­Ò½ÔºÂé×í¿Æ¡¶Öé½­Êӽ硷·­ÒëС×éÿÔÂͨ¹ýÖ÷Ìâ´Ê¼ìË÷£¬´ÓPubMedÓëWeb of ScienceµÈ¼ìË÷ÒýÇæ£¬É¸Ñ¡³ö½üÆÚ¹úÄÚÂé×íѧ¿ÆËù·¢±íµÄ¸ßÖÊÁ¿SCIÎÄÏ×ÓëÑо¿³É¹û£¬½øÐÐÕªÒªµ¼¶ÁµÄͬʱͨ¹ý¡¶ÐÂÇàÄêÂé×íÂÛ̳¡·Öé½­ÊÓ½çרÀ¸ÒÔÿÔºÃÎĵķ½Ê½ÏòÈ«¹úͬµÀÍÆ½é¡£


±¾ÆÚ¡¶Öé½­ÊÓ½ç-ÿÔºÃÎÄ¡·½ÚÑ¡2023Äê8-2023Äê9Ô·¢±íµÄ²¿·ÖÎÄÕ£¬Ñо¿À´×ÔÄÏ·½Ò½¿Æ´óѧÉúÎïҽѧ¹¤³ÌѧԺ¡¢±±¾©Ð­ºÍÒ½Ôº¡¢¸´µ©´óѧ¸½ÊôÖÐɽҽԺ¡¢ÖÐÄÏ´óÑ§ÏæÑÅÈýÒ½ÔºµÈ£¬ÄÚÈݺ­¸Ç³¦µÀ¾úȺʧµ÷¡¢·ÎÒÆÖ²¡¢ÊõºóÚÞÍýÐÐΪ¡¢°¢Æ¬ÀàÓÃÒ©µÈ·½ÃæÄÚÈÝ£¨#ΪµÚÒ»×÷Õߣ¬*ΪͨѶ×÷Õߣ©¡£

ÿÔºÃÎÄ£¨2022.08-2023.09£©Ö®ÏÂ

15. Ling Hanzhi#, Lin Yufan, Bao Weilei, et al. Shengwei Jin*. Erythropoietin-mediated IL-17 F attenuates sepsis-induced gut microbiota dysbiosis and barrier dysfunction. Biomed Pharmacother, 2023, 165: 115072.PMID£º37390712

¡¾ÌâÄ¿¡¿

´Ùºìϸ°ûÉú³ÉËØ½éµ¼µÄIL-17 F¿É¼õÇáŧ¶¾Ö¢ÓÕµ¼µÄ³¦µÀ΢ÉúÎïȺʧµ÷ºÍÆÁÕϹ¦ÄÜÕϰ­

¡¾Í¨Ñ¶×÷Õß¡¿

½ðʤÍþ  ÎÂÖÝÒ½¿Æ´óѧµÚ¶þ¸½ÊôÒ½Ôº¡¢ÓýÓ¢¶ùͯҽԺÂé×íÓëÖØÖ¢¼à»¤ÊÒ£»

¡¾µÚÒ»×÷Õß¡¿

Ling Hanzhi  ÎÂÖÝÒ½¿Æ´óѧ»ù´¡Ò½Ñ§ÔºÉúÎﻯѧϵ£»

¡¾ÕªÒª¡¿

ŧ¶¾Ö¢³¦µÀËðÉËÔÚŧ¶¾Ö¢ºÍ¶àÆ÷¹ÙË¥½ßµÄ½øÕ¹ÖÐÖÁ¹ØÖØÒª£¬ÆäÌØÕ÷Êdz¦µÀ΢ÉúÎïȺʧµ÷ºÍ³¦µÀÆÁÕÏÉÏÆ¤È±·¦¡£×î½üµÄÑо¿Ç¿µ÷´Ùºìϸ°ûÉú³ÉËØ£¨EPO£©¶Ô¶à¸öÆ÷¹ÙµÄ±£»¤×÷Óᣱ¾Ñо¿·¢ÏÖ£¬EPOÖÎÁÆ¿ÉÏÔÖøÌá¸ßŧ¶¾Ö¢Ð¡ÊóµÄ´æ»îÂÊ£¬ÒÖÖÆÑ×Ö¢·´Ó¦£¬¸ÄÉÆ³¦µÀËðÉË¡£EPOÖÎÁÆÒ²Äæ×ªÅ§¶¾Ö¢ÒýÆðµÄ³¦µÀ΢ÉúÎïȺʧµ÷¡£EPOR»ùÒòÇóýºó£¬EPOÔÚ³¦µÀÆÁÕϺÍ΢ÉúÎïȺÖеı£»¤×÷ÓÃÊÜËð¡£ÖµµÃ×¢ÒâµÄÊÇ£¬ÎÒÃÇ´´ÐÂÐÔµØÖ¤Ã÷ͨ¹ýת¼×é²âÐòɸѡµÄIL-17 F¿É¸Äɯŧ¶¾Ö¢ºÍŧ¶¾Ö¢ÐÔ³¦µÀËðÉË£¬°üÀ¨³¦µÀ΢ÉúÎïȺʧµ÷ºÍÆÁÕϹ¦ÄÜÕϰ­£¬IL-17 F´¦ÀíµÄ·à±ã΢ÉúÎïÈºÒÆÖ²£¨FMT£©Ò²ÑéÖ¤ÕâÒ»µã¡£ÎÒÃǵÄÑо¿½á¹ûÇ¿µ÷EPO½éµ¼µÄIL-17 Fͨ¹ý»º½â³¦µÀÆÁÕϹ¦ÄÜÕϰ­ºÍ»Ö¸´³¦µÀ΢ÉúÎïȺʧµ÷ÔÚŧ¶¾Ö¢ÒýÆðµÄ³¦µÀËðÉËÖеı£»¤×÷Óá£EPOºÍIL-17 F¿ÉÄÜÊÇŧ¶¾Ö¢»¼ÕßµÄDZÔÚÖÎÁưе㡣

16. Kaibin Wu #, Dijia Wang , Yuwei Wang , Peiwen Tang , Xuan Li , Yidi Pan , Huizhong W Tao , Li I Zhang , Feixue Liang*. Distinct circuits in anterior cingulate cortex encode safety assessment and mediate flexibility of fear reactions. Neuron, 2023.Aug 8. PMID: 37652003

¡¾ÌâÄ¿¡¿

ǰ¿Û´øÆ¤²ãÖеIJ»Í¬»ØÂ·±àÂëÁ˰²È«ÆÀ¹À²¢½éµ¼¿Ö¾å·´Ó¦µÄÁé»îÐÔ

¡¾Í¨Ñ¶×÷Õß¡¿

Áºåúѧ  ÄÏ·½Ò½¿Æ´óѧÉúÎïҽѧ¹¤³ÌѧԺ£¬ÄÏ·½Ò½¿Æ´óѧÔÁ¸Û°Ä´óÍåÇøÄÔ¿ÆÑ§ÓëÀàÄÔÑо¿ÖÐÐÄ£¬ÄÏ·½Ò½¿Æ´óѧÐÄÀí½¡¿µ½ÌÓý²¿ÖصãʵÑéÊÒ£¬ÄÏ·½Ò½¿Æ´óѧÖé½­Ò½ÔºÂé×í¿Æ£¬ÄÏ·½Ò½¿Æ´óѧ¹ã¶«Ê¡¾«Éñ¼²²¡ÖصãʵÑéÊÒ£¬ÄÏ·½Ò½¿Æ´óѧ¹«¹²ÎÀÉúѧԺÐÄÀíϵ£»

¡¾µÚÒ»×÷Õß¡¿

ÎâïÇïÙ£¬ÍõµÚ¼×£¬ÌÆÅåÎÄ  ÄÏ·½Ò½¿Æ´óѧÉúÎïҽѧ¹¤³ÌѧԺ£¬ÄÏ·½Ò½¿Æ´óѧÔÁ¸Û°Ä´óÍåÇøÄÔ¿ÆÑ§ÓëÀàÄÔÑо¿ÖÐÐÄ£¬ÄÏ·½Ò½¿Æ´óѧÐÄÀí½¡¿µ½ÌÓý²¿ÖصãʵÑéÊÒ£¬ÄÏ·½Ò½¿Æ´óѧÖé½­Ò½ÔºÂé×í¿Æ£¬ÄÏ·½Ò½¿Æ´óѧ¹ã¶«Ê¡¾«Éñ¼²²¡ÖصãʵÑéÊÒ£»
ÍõÓêÞ±  ÄÏ·½Ò½¿Æ´óѧ¹«¹²ÎÀÉúѧԺÐÄÀíϵ£»

¡¾ÕªÒª¡¿

¶Ô¶¯Îï¶øÑÔ£¬°²È«ÆÀ¹ÀºÍÍþвÆÀ¹ÀÔÚÒ°ÍâÉú»îºÍÉú´æÖÐÖÁ¹ØÖØÒª¡£È»¶ø£¬ÓÃÓÚ°²È«ÆÀ¹ÀµÄÉñ¾­»ØÂ·¼°Æäµ÷½Ú¿Ö¾åÒýÆðµÄ·ÀÓùÐÐΪµÄÁé»îÐÔת±äÉв»Çå³þ¡£ÔÚÕâÀÎÒÃDZ¨¸æÁËСÊóǰ¿Û´øÆ¤²ã£¨ACC£©Öв»Í¬µÄÉñ¾­ÔªÈºÔÚ²»Í¬µÄÌý¾õÍþв±³¾°Ï£¬Í¨¹ýÑ¡ÔñÐÔ·´Ó¦À´±àÂ밲ȫ״̬£¬ÆäÖÐÒ»¸öÉñ¾­ÔªÈºÔÚ¶¯ÎïÍ£ÁôÔÚ×ÔÈÏΪ°²È«µÄÇøÓòʱÓÅÏȱ»¼¤»î£¬ÁíÒ»¸öÔòÔÚ¸üΣÏյĻ·¾³Ï±»¼¤»î£¬´Ó¶ø±àÂë²úÉúÌÓÒÝÐÐΪ¡£°²È«·´Ó¦Éñ¾­ÔªÓÅÏÈͶÉäÖÁ䶨´ø£¨ZI£©£¬Æäͨ¹ýGABAÄÜ´«µ¼ÒÖÖÆÉÏÇðÄÔ£¨SC£©£¬¶øÏìӦΣÏÕµÄÉñ¾­ÔªÔò¸üÇãÏòÓÚ°ÐÏòºÍÐË·ÜSC¡£ÕâЩ²»Í¬µÄƤÖÊÏÂÐÐͨ·¶ÔSCµÄÍþв·´Ó¦½øÐжԿ¹ÐÔµ÷¿Ø£¬µ¼Ö¿־巴ӦÇé¾³ÒÀÀµÐÔ±í´ï¡£Òò´Ë£¬ACCͨ¹ý²»Í¬µÄ×ÔÉ϶øÏ´«µ¼»ØÂ·£¬³ÉΪ±àÂ밲ȫ»òΣÏÕÆÀ¹À²¢½éµ¼ÐÐΪÁé»îÐԵĹؼü½Úµã¡£


17. Yaodan Bi#,Yinchao Zhu,Shuai Tang*,Yuguang Huang. Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study. J Headache Pain, 2023.Aug 18. PMID: 37596566

¡¾ÌâÄ¿¡¿
Ö¬ÖÊ¡¢µ÷Ö¬Ò©Îï°Ð»ùÒòÓëÆ«Í·Í´£ºÒ»ÏîÃϵ¶ûËæ»ú»¯Ñо¿

¡¾Í¨Ñ¶×÷Õß¡¿
ÌÆË§  Öйúҽѧ¿ÆÑ§Ôº£¬±±¾©Ð­ºÍҽѧԺ±±¾©Ð­ºÍÒ½ÔºÂé×í¿Æ£»

¡¾µÚÒ»×÷Õß¡¿
±ÏÒ«µ¤  Öйúҽѧ¿ÆÑ§Ôº£¬±±¾©Ð­ºÍҽѧԺ±±¾©Ð­ºÍÒ½ÔºÂé×í£»
ÖìÒø³¬  ËÄ´¨´óѧ¸½Êô»ªÎ÷Ò½ÔºÂé×í¿Æ£»

¡¾ÕªÒª¡¿
ÒýÑÔ£ºÆ«Í·Í´ÊÇÒ»ÖÖ³£¼ûµÄÍ·Í´¼²²¡£¬Æä»úÖÆ²»Çå³þÇÒÖÎÁÆ·½·¨ÓÐÏÞ£¬¿ÉÄÜÊܵ½ÑªÖ¬Òì³£ºÍÒÅ´«ÒòËØµÄÓ°Ïì¡£ËûÍ¡ÀàÒ©ÎïºÍÐÂÐ˵ĵ÷Ö¬Ò©ÎïÏÔʾ³öDZÁ¦£¬µ«È±·¦ÖÎÁÆÆ«Í·Í´µÄÖ¤¾Ý¡£Ãϵ¶ûËæ»ú·ÖÎöÌṩÁ˶ÔÒò¹û¹ØÏµºÍÖÎÁưеãµÄ¼û½â¡£±¾Ñо¿Ö¼ÔÚ̽Ë÷»ùÒòÔ¤²âµÄÖ¬ÖÊÌØÕ÷¡¢Ò©Îï°Ðµã¼°ÆäÓëÆ«Í·Í´·çÏյĹØÁª¡£

·½·¨£ºÎÒÃÇÀûÓÃÓëÖ¬ÖÊÌØÕ÷Ïà¹ØµÄÒÅ´«±äÒìÒÔ¼°±àÂë¸÷Àཱུ֬ҩÎï°Ð±êµ°°×µÄ»ùÒò±äÒì½øÐÐÃϵ¶ûËæ»ú»¯·ÖÎö·ÖÎö¡£¾ßÌåÑо¿µÄÒ©ÎïÀà±ð°üÀ¨HMGCR¡¢PCSK9¡¢NPC1L1¡¢ABCG5/ABCG8¡¢LDLR¡¢LPL¡¢ANGPTL3¡¢APOB¡¢CETPºÍAPOC3¡£ÎªÁËÈ·¶¨¶Ôƫͷʹ·çÏÕµÄÓ°Ï죬ÎÒÃÇʹÓÃÁ½¸ö´óÑù±¾¼¯µÄÊý¾Ý¶ÔÇøÓò±äÒìµÄMR¹À¼Æ½øÐÐmeta·ÖÎö¡£»ùÒò±äÒì¸ù¾ÝÆäÓëÌØ¶¨Ö¬ÖÊÌØÕ÷µÄ¹ØÁª½øÐмÓȨ£¬ÈçµÍÃܶÈÖ¬µ°°×µ¨¹Ì´¼£¨LDL-C£©¡¢¸ßÃܶÈÖ¬µ°°×µ¨¹Ì´¼£¨HDL-C£©¡¢ÔØÖ¬µ°°×A1ºÍÔØÖ¬µ°°×B¡£ÎªÁË»ñµÃ¹ØÁªÈ¨ÖØ£¬ÎÒÃÇÀûÓÃÁËÖ¬ÖÊÒÅ´«Ñ§ÁªÃ˵ÄÊý¾Ý¡£¶ÔÓÚ¾ßÓÐÌáʾÒâÒåµÄµ÷Ö¬Ò©Îï°Ð±ê£¬ÎÒÃǽøÒ»²½ÔËÓñí´ïÁ¿ÐÔ×´»ùÒò×ù£¨eQTL£©Êý¾Ý¡£´ËÍ⣬ÎÒÃÇ»¹½øÐÐÁ˹²¶¨Î»·ÖÎöÒÔÆÀ¹ÀÒÅ´«»ìÔÓЧӦ¡£

½á¹û£ºÔÚFinnGenÊý¾Ý¼¯ÖУ¬Ê¹ÓÃÒÅ´«´úÀíÒÖÖÆHMGCRÓëÆ«Í·Í´·çÏÕ½µµÍÏÔÖøÏà¹Ø£¨OR=0.64£¬95% CI£º0.46-0.88£¬p=0.0006£©£¬ÔÚChoquetÊý¾Ý¼¯ÖÐÒ²ÏÔʾ³öÏà½üµÄÏÔÖøÏà¹ØÐÔ£¨OR=0.78£¬95% CI£º0.60-1.01£¬p=0.06£©¡£µ±ºÏ²¢¹À¼ÆÖµÊ±£¬×ÜÌåЧӦÏÔʾƫͷʹ·çÏÕ½µµÍ£¨OR=0.73£¬95% CI£º0.60-0.89£¬p=0.0016£©¡£ÀàËÆµØ£¬ÔÚFinnGenÊý¾Ý¼¯£¨OR=0.82£¬95% CI£º0.69-0.96£¬p=0.01£©ºÍChoquetÊý¾Ý¼¯£¨OR=0.91£¬95% CI£º0.83-0.99£¬p=0.03£©ÖУ¬LPLÔöÇ¿µÄÒÅ´«Ä£ÄâÓëÆ«Í·Í´·çÏսϵÍÏà¹Ø¡£ºÏ²¢¹À¼ÆÏÔʾһÖµÄЧӦ´óС£¨OR=0.89£¬95% CI£º0.83-0.96£¬p=0.002£©¡£Ãô¸ÐÐÔ·ÖÎöûÓеóöͳ¼ÆÑ§ÉÏÏÔÖøµÄÖ¤¾ÝÒÔ±íÃ÷¶àЧÐÔ»òÒÅ´«»ìÔÓÒýÆðµÄÆ«²î¡£

½áÂÛ£ºÑо¿Öй۲쵽£¬ÔÚµ÷²éµÄ10¸ö½µÖ¬Ò©Îï°ÐµãÖУ¬LPLºÍHMGCRÓëÆ«Í·Í´·çÏÕÓÐÏÔÖø¹ØÁª¡£ÕâЩ·¢ÏÖ±íÃ÷LPLºÍHMGCRÓÐDZÁ¦×÷ΪÖÎÁÆ»òÔ¤·ÀƫͷʹµÄºòѡҩÎï°Ðµã¡£

18. Qian Chen#, Xiangfeng Liu#, Zhiheng Liu# , Shujing Zhang , Lin Chen , Shiori Eguchi , Azeem Alam , Zhen Cahilog , Qizhe Sun , Lingzhi Wu , Enqiang Chang , Zhiping Wang , Jianteng Gu* , Hailin Zhao , Daqing Ma*.Tackling regulated cell death yields enhanced protection in lung grafts. Theranostics, 2023.Jul 31. PMID: 37649611

¡¾ÌâÄ¿¡¿

½â¾öÊܵ÷½ÚµÄϸ°ûËÀÍö¿ÉÒÔÔöÇ¿¶Ô·ÎÒÆÖ²ÎïµÄ±£»¤


¡¾Í¨Ñ¶×÷Õß¡¿

¹Ë½¡ÌÚ  Â½¾ü¾üÒ½´óѧÎ÷ÄÏÒ½ÔºÂé×í¿Æ£»

Âí´óÇà  Ó¢¹úÂ׶ص۹úÀí¹¤Ñ§ÔºÒ½Ñ§Ôº¸½ÊôÇжûÎ÷ºÍÍþ˹ÃôË¹ÌØÒ½ÔºÍâ¿ÆÓ방֢ѧϵÂé×í¡¢ÌÛʹҽѧÓëÖØÖ¢¼à»¤·Ö²¿£¬Õã½­´óѧҽѧԺ¸½Êô¶ùͯҽԺ¹ú¼Ò¶ùͯ±£½¡ÁÙ´²Ñо¿ÖÐÐÄ£»

¡¾µÚÒ»×÷Õß¡¿

³ÂÙ»  Ó¢¹úÂ׶ص۹úÀí¹¤Ñ§ÔºÒ½Ñ§Ôº¸½ÊôÇжûÎ÷ºÍÍþ˹ÃôË¹ÌØÒ½ÔºÍâ¿ÆÓ방֢ѧϵÂé×í¡¢ÌÛʹҽѧÓëÖØÖ¢¼à»¤·Ö²¿£¬Õã½­´óѧҽѧԺ¸½Êô¶ùͯҽԺ¹ú¼Ò¶ùͯ±£½¡ÁÙ´²Ñо¿ÖÐÐÄ£»
ÁõÏé·ï  Â½¾ü¾üÒ½´óѧ¸½ÊôÎ÷ÄÏÒ½ÔºÂé×í¿Æ£»
ÁõÖ¾ºã  ÉîÛÚÊеڶþÈËÃñÒ½Ôº/ÉîÛÚ´óѧµÚÒ»¸½ÊôҽԺҽѧ¿ÆÑ§ÖÐÐÄÂé×í¿Æ£»

¡¾ÕªÒª¡¿

±³¾°£ºÐèÒªÓÐЧµÄ±£´æ²ßÂÔÀ´¸ÄÉÆ·ÎÒÆÖ²ÎïµÄȱѪÐÔËðÉË£¬ÒÔÍì¾È¡°À©Õ¹±ê×¼¡±»ò¡°±ßÔµ¡±·ÎÒÆÖ²£¬²¢ÔÚÒÆÖ²ºó¸ÄÉÆÊÜÌåµÄÔ¤ºó½á¹û¡£


·½·¨£ºÐÄÔàÑ­»·ËÀÍö40·ÖÖӺ󣬴ÓÐÛÐÔLewis´óÊóÖÐÈ¡³ö·ÎÒÆÖ²Î²¢´ÓÐзÎÒ¶ÇгýÊõµÄ»¼ÕßÖÐÊÕ¼¯½¡¿µµÄÈËÀà·Î×éÖ¯¡£È»ºó½«·ÎÑùÆ·±£´æÔÚ²¹³äÓÐ0.1nMÓÒÃÀÍÐß䶨£¨Dex£¬¦Á2-ÉöÉÏÏÙËØÊÜÌ弤¶¯¼Á£©µÄ4¡æ±£´æÒºÖÐ16Сʱ¡£ÔÚÌåÍâʵÑéÖУ¬½«ÈË·ÎÉÏÆ¤A549ϸ°û±£´æÔÚº¬ÓÐ0.1nMÓÒÃÀÍÐß䶨µÄ4¡ãC±£´æÈÜÒºÖб£´æ24Сʱ£¬È»ºóÔÚ37¡ãCµÄÅàÑø»ùÖÐÖØÐÂÅàÑø£¬ÒÔÄ£ÄâµÍÎÂȱѪºÍÈÈÔÙ¹à×¢µÄÁÙ´²Çé¿ö¡£È»ºóʹÓöàÖÖ¼¼Êõ£¨°üÀ¨µ°°×ÖÊÓ¡¼£¡¢ÃâÒßȾɫºÍµç×ÓÏÔ΢¾µ£©¶Ô·Î×éÖ¯ºÍϸ°û½øÐзÖÎö£¬ÒÔÈ·¶¨ÓÒÃÀÍÐß䶨µÄËðÉ˺ͱ£»¤×÷Óá£

½á¹û£ºÐÄÔàÑ­»·ËÀÍöºó³¤Ê±¼äµÄÈÈȱѪÒý·¢ÁËRip¼¤Ã¸½éµ¼µÄ»µËÀÐÔµòÍö£¬¶øÀä±£´æ»á¼Ó¾çÕâÖÖ»µËÀÐÔµòÍö£¬½ø¶øÔöÇ¿·ÎÒÆÖ²ËðÉË¡£ÓÒÃÀÍÐß䶨ͨ¹ýÉϵ÷Nrf2»î»¯ºÍ¼õÉÙÑõ»¯Ó¦¼¤×÷ÓÃÏÔÖø½µµÍÁË»µËÀÐÔϸ°ûµòÍö£¬´Ó¶øÏÔÖø¸ÄÉÆÁË·ÎÒÆÖ²ÎïÐÎ̬¡£ÓÒÃÀÍÐß䶨ÖÎÁÆ»¹¿ÉÒÔ¼õÇáÄÚÖÊÍøÓ¦¼¤£¬Îȶ¨ÈÜøÌå²¢´Ù½øÏ¸°ûĤÔÙ·â±Õ¹¦ÄÜ£¬´Ó¶ø¼õÉÙÁËA549ϸ°ûÔÚµÍÎÂȱÑõ¸´ÑõºóµÄϸ°ûËÀÍöºÍÑ×Ö¢¼¤»î¡£

½áÂÛ£ºÍ¨¹ýÔÚÒÆÖ²Îï±£´æÒºÖÐÌí¼ÓÓÒÃÀÍÐß䶨À´À´ÒÖÖÆµ÷½ÚÐÔϸ°ûËÀÍö£¬¿ÉÒÔ¸ÄÉÆÒÆÖ²ÎïµÄÖÊÁ¿£¬´Ó¶øÓÐÖúÓÚÀ©´ó¹©Ìå·Î×ÊÔ´£¬²¢Ìá¸ß·ÎÒÆÖ²ÊõµÄÔ¤ºó½á¹û¡£

19. Hui-Min Zhou# , Heng-Jun Xu , Run-Hang Sun, Ming Zhang , Xiao-Tong Li, Ya-Xuan Zhao , Kehui Yang , Runa Wei , Qiaoqiao Liua, Siyuan Li , Zhouya Xue, Ling-Yun Hao , Li Yang , Qi-Hui Wang , Hong-Jun Wang, Fang Gao , Jun-Li Cao , Zhiqiang Pan*.DNA N6-methyladenine methylase N6AMT1 controls neuropathic pain through epigenetically modifying Kcnj16 in dorsal horn neurons. Pain. 2023 Aug 25. PMID: 37624905.

¡¾ÌâÄ¿¡¿

DNA N6-¼×»ùÏÙàÑßʼ׻ù»¯Ã¸N6AMT1ͨ¹ý±í¹ÛÒÅ´«ÐÞÊα³½ÇÉñ¾­ÔªKcnj16µ÷½ÚÉñ¾­²¡ÀíÐÔÌÛÍ´


¡¾Í¨Ñ¶×÷Õß¡¿

ÅË־ǿ  ÐìÖÝÒ½¿Æ´óѧ½­ËÕÊ¡Âé×íÑ§ÖØµãʵÑéÊÒ£»

¡¾µÚÒ»×÷Õß¡¿

Hui-Min Zhou  ÐìÖÝÒ½¿Æ´óѧ½­ËÕÊ¡Âé×íÑ§ÖØµãʵÑéÊÒ£»

¡¾ÕªÒª¡¿

Éñ¾­ËðÉËÓÕµ¼µÄ¼¹Ëè±³½ÇÉñ¾­Ôª»ùÒò±í´ïÒì³£ÊÇÉñ¾­²¡ÀíÐÔÌÛÍ´·¢ÉúµÄ¹Ø¼ü¡£DNAµÄN6-¼×»ùÏÙàÑßÊ£¨m6A£©ÐÞÊÎÊÇ»ùÒòµ÷¿ØµÄÒ»ÖÖµ÷½Ú·½Ê½¡£ÎÒÃǵÄÑо¿·¢ÏÖÖÜΧÉñ¾­ËðÉËÏÔÖø½µµÍÁ˱³½ÇÉñ¾­ÔªÖÐm6AÌØÒìÐÔDNA¼×»ù×ªÒÆÃ¸1£¨N6amt1£©µÄˮƽ£¬ÕâÖÖÓ°ÏìÖÁÉÙ²¿·Ö¹éÒòÓÚת¼Òò×ÓNr2f6µÄ¼õÉÙ¡£¸ÄÉÆN6amt1ˮƽµÄϽµÄæ×ªÁËÄÚÏòÕûÁ÷¼ØÍ¨µÀÑǼÒ×åJ³ÉÔ±16 (Kcnj16)Æô¶¯×ÓÇøm6AµÄ¶ªÊ§£¬¼õÇáÁËÉñ¾­ËðÉËÒýÆðµÄ¼¹Ëè±³½ÇKcnj16±í´ïÉϵ÷£¬¼Ì¶ø¼õÇáÉñ¾­²¡ÀíÐÔÍ´Ãô¡£Ïà·´£¬ÔÚÒ°ÉúÐÍСÊóÄ£ÄâN6amt1ϵ÷È¥³ýKcnj16Æô¶¯×ÓÇøDNA m6Aºó£¬Kcnj16±í´ïÉý¸ß£¬Ð¡Êó³öÏÖÁËÉñ¾­²¡ÀíÐÔÌÛÍ´ÑùÐÐΪ¡£Òò´Ë£¬NR2F6ÒýÆðµÄN6amt1¼õÉÙÊÇÉñ¾­²¡ÀíÐÔÌÛÍ´·¢ÉúËù±ØÐèµÄ£¬Æä¿ÉÄÜͨ¹ýµ÷¿Ø±³½ÇÉñ¾­ÔªÖÐm6A¿ØÖƵÄKCNJ16ʵÏÖ£¬ÌáʾDNA m6AÐÞÊοÉÄÜÊÇÒ»¸öDZÔÚµÄеÄÕòÍ´ºÍÖÎÁưе㡣


20. Xue Yang# ,Jiang Wang, Xiaowen Dai , Ning Ma ,Hu Cheng , Hai Guo , Siyu Chen , Yidan Huang , and Jianjiang Wu*.The Mechanism and Targeted Intervention of the HIF-1 Pathway in Improving Atherosclerotic Heart's Sensitivity to Ischemic Postconditioning.Free Radic Biol Med.2023 Sep 1:S0891-5849(23)00610-X. PMID: 37660838.

¡¾ÌâÄ¿¡¿
°ÐÏò¸ÉÔ¤HIF-1ͨ·¸ÄÉÆ¶¯ÂöÖàÑùÓ²»¯ÐÄÔà¶ÔȱѪºó´¦ÀíÃô¸ÐÐÔ¼°Æä»úÖÆ

¡¾Í¨Ñ¶×÷Õß¡¿
Î⽨½­  Ð½®Ò½¿Æ´óѧµÚÒ»¸½ÊôÒ½ÔºÂé×í¿Æ£»

¡¾µÚÒ»×÷Õß¡¿
Xue Yang  Ð½®Ò½¿Æ´óѧµÚÒ»¸½ÊôÒ½ÔºÂé×í¿Æ£»

¡¾ÕªÒª¡¿
±³¾°£ºIPoC¶Ô½¡¿µÐÄȱѪÔÙ¹à×¢ËðÉË£¨IR£©¾ßÓÐÔ¤·À×÷Ó㬵«¶Ô¶¯ÂöÖàÑùÓ²»¯Ðı£»¤×÷ÓôæÔÚÕùÒé¡£±¾Ñо¿Ö¼ÔÚÈ·¶¨IPoCÔÚ¶¯ÂöÖàÑùÓ²»¯Ðļ¡È±ÑªÔÙ¹à×¢ËðÉËÖÐÊÇ·ñÈÔÈ»¾ßÓб£»¤×÷Óã»Ì½ÌÖIPoC·¢»ÓÐ£»¤×÷ÓõľßÌå»úÖÆ£»Ì½ÌÖHIF-1Éϵ÷ÁªºÏIPoCÄÜ·ñ½øÒ»²½ÌṩÐ£»¤£»²¢Ì½ÌÖÁªºÏÖÎÁƶÔÐÄÔà±£»¤×÷ÓõľßÌå»úÖÆ¡£

·½·¨£º¸øÓèApoE-/-СÊó¸ßÖ¬ÒûʳÒÔ½¨Á¢¶¯ÂöÖàÑùÓ²»¯Ä£ÐÍ¡£²ÉÓýáÔú×óǰ½µÖ§45 minÔÙ¹à×¢120 minµÄ·½·¨½¨Á¢´óÊóÐļ¡È±ÑªÔÙ¹à×¢ËðÉËÄ£ÐÍ¡£Í¨¹ý¼ì²âÑõ»¯Ó¦¼¤¡¢Ï¸°ûµòÍö¡¢¹£ËÀÃæ»ý¡¢Ð¡Àíѧ¡¢ÏßÁ£Ì幦ÄÜÕϰ­ºÍÐļ¡ÐÎ̬ѧÀ´ÆÀ¼ÛIPoC¶Ô½¡¿µÐļ¡ºÍ¶¯ÂöÖàÑùÓ²»¯Ðı£»¤×÷Óá£Í¨¹ý¼ì²âHIF-1¡¢AMPKºÍRISKͨ·Ïà¹Øµ°°×µÄ±í´ï£¬¹Û²ìIPoC¶Ô½¡¿µºÍ¶¯ÂöÖàÑùÓ²»¯Ðļ¡·¢»ÓÐ£»¤×÷ÓõľßÌå»úÖÆ¡£Í¨¹ý¾²Âö×¢ÉäAAV9-HIF-1¦Á¹Û²ì¹ý±í´ïHIF-1¦Á¶ÔIPoCÐ£»¤×÷ÓõÄÓ°Ïì¡£

½á¹û£ºÔÚ½¡¿µµÄȱѪÐļ¡ÖУ¬IPoCͨ¹ý¼¤»îHIF-1¡¢AMPKºÍRISKͨ··¢»ÓÐ£»¤×÷Ó㨿¹Ñõ»¯¡¢¿¹µòÍöºÍ¸ÄÉÆÏßÁ£Ì幦ÄÜ£©¡£ÔÚ¶¯ÂöÖàÑùÓ²»¯È±ÑªÐļ¡ÖУ¬IPoC½öͨ¹ý¼¤»îHIF-1ͨ··¢»ÓÐ£»¤×÷Óã»¶øHIF-1¹ý±í´ïÁªºÏIPoC»Ö¸´ÁËAMPKºÍRISKͨ·µÄ¼¤»î£¬´Ó¶ø½øÒ»²½¼õÇáÐļ¡IRËðÉË¡£

½áÂÛ£ºÔÚ¶¯ÂöÖàÑùÓ²»¯×´Ì¬Ï£¬HIF-1ͨ·ÊÇIPoC·¢»ÓÐ£»¤×÷ÓõÄÄÚÔÚ»úÖÆ¡£Éϵ÷HIF-1ÁªºÏIPoCÔÚ¼õÇáÐļ¡ËðÉË·½ÃæÐ§¹ûÏÔÖø£¬ÖµµÃ½øÒ»²½Ñо¿ºÍÍÆ¹ã¡£´ËÍ⣬HIF-1- AMPKºÍHIF-1-RISK¿ÉÄÜÊÇÁ½Ìõ¾ßÓÐÖØÒª¼ÛÖµµÄÄÚÔ´ÐÔÐ£»¤ÐźÅͨ·£¬ÖµµÃ½øÒ»²½ÉîÈëÑо¿¡£

21. Xiaobin Fang#, Yueyi Weng, and Xiaochun Zheng*. Involvement of CCL2 and CH25H Genes and TNF signaling pathways in mast cell activation and pathogenesis of chronic spontaneous urticaria. Front Immunol, 2023 Aug 14. PMID: 37646031

¡¾ÌâÄ¿¡¿

CCL2ºÍCH25H»ùÒò¼°TNFÐźÅͨ·²ÎÓë·Ê´óϸ°û»î»¯ºÍÂýÐÔ×Ô·¢ÐÔÝ¡ÂéÕîµÄ·¢²¡¹ý³Ì

¡¾Í¨Ñ¶×÷Õß¡¿

Ö£Ïþ´º  ¸£½¨Ò½¿Æ´óѧʡÁ¢ÁÙ´²Ò½Ñ§Ôº£¬¸£½¨Ê¡Á¢Ò½ÔºÂé×í¿Æ£¬¸£½¨Ê¡¼±ÕïҽѧÖÐÐÄ£¬¸£½¨Ê¡¼±ÕïÒ½Ñ§ÖØµãʵÑéÊÒ£¬¸£½¨Ê¡ÖØÖ¢Ò½Ñ§ÖصãʵÑéÊÒ£»

¡¾µÚÒ»×÷Õß¡¿

Xiaobin Fang  ¸£½¨Ò½¿Æ´óѧʡÁ¢ÁÙ´²Ò½Ñ§Ôº£¬¸£½¨Ê¡Á¢Ò½ÔºÂé×íÓëÖØÖ¢Ò½Ñ§½ÌÑÐÊÒ£¬¸£½¨Ê¡ÖØÖ¢Ò½Ñ§ÖصãʵÑéÊÒ£»

¡¾ÕªÒª¡¿

ÂýÐÔ×Ô·¢ÐÔÝ¡ÂéÕChronic spontaneous urticaria£¬CSU£©ÊÇÒ»ÖÖÓÉ·Ê´óϸ°ûÇý¶¯µÄ¼²²¡£¬ÑÏÖØÓ°Ï컼ÕßµÄÉú»îÖÊÁ¿¡£ÒÅ´«ÒòËØ¿ÉÓ°ÏìCSUµÄÒ׸ÐÐÔºÍÑÏÖØ³Ì¶È£¬µ«ÓëCSUÖзʴóϸ°û¼¤»îÏà¹ØµÄÌØ¶¨ÒÅ´«ÒòËØÈÔÓдý²ûÃ÷¡£ÎÒÃǵÄÑо¿Ä¿µÄÊÇÕÒ³öÆäÖйؼüµÄÒÅ´«ÒòËØ£¬²¢Ñо¿ËüÃÇÔÚCSU·¢²¡ÖеÄ×÷Óá£ÎÒÃǽ«À´×Ô»ùÒò±í´ï×Ü¿âÖеÄÁ½¸ö»ùÒò±í´ïÊý¾Ý¼¯½øÐÐÁ˺ϲ¢£¬²¢Ê¹ÓÃÖ÷³É·Ö·ÖÎöºÍ·½¿òͼ½øÐÐÑéÖ¤¡£¶ÔºÏ²¢ºóµÄÊý¾Ý¼¯½øÐÐlimmaºÍ¼ÓȨ»ùÒò¹²±í´ïÍøÂç·ÖÎö¡£Í¨¹ý»ùÒò¼¯¸»¼¯·ÖÎö£¨GSEA£©¡¢»ùÒò±¾Ì壨GO£©Êý¾Ý¿âºÍ¾©¶¼»ùÒòÓë»ùÒò×é°Ù¿ÆÈ«Ê飨KEGG£©Êý¾Ý¿â¸»¼¯·ÖÎö£¬¼ø¶¨²¢·ÖÎöÓëCSU¸ß¶ÈÏà¹ØµÄ»ùÒò¡£GSEA¡¢GOºÍKEGG·ÖÎöÍ»ÏÔÁËÇ÷»¯Òò×Ó£¨C-CÄ£Ì壩ÅäÌå2£¨CCL2£©ºÍµ¨¹Ì´¼25ôÇ»ùø£¨CH25H£©»ùÒòºÍÖ×Áö»µËÀÒò×Ó£¨TNF£©ÐźÅͨ·ÔÚCSUÖеÄÖØÒªÐÔ£»ÔÚÈË·Ê´óϸ°ûϵ-1£¨HMC-1£©ÖÐÇüõÕâÈý¸öÏàÓ¦»ùÒò£¬È»ºóÓÃÄýѪø·õÓýÒÔÄ£ÄâCSUµÄ·¢²¡¹ý³Ì¡£¶ÔCCL2¡¢CH25HºÍTNF»ùÒòµÄÇüõ½µµÍÁËHMC-1µÄÐË·ÜÐÔºÍϸ°ûÒò×ӵIJúÉú¡£ÎÒÃǵÄÑо¿½á¹û±íÃ÷£¬CCL2¡¢CH25HºÍTNFͨ·µÄÏà¹Ø»ùÒòÔÚCSU·¢²¡»úÖÆÖÐÆð׏ؼü×÷Óã¬ÕâΪѰÕÒÖÎÁÆCSUµÄDZÔÚÖÎÁưеãÌṩÁ˲ο¼¡£


22. Suai-Nan Zhu#, Ying Yu, Meng-Di Qu, Zhi-Yun Qiu, Hao Zhang, Chang-Hong Miao, Ke-Fang Guo*. Neutrophil extracellular traps contribute to immunothrombosis formation via the STING pathway in sepsis-associated lung injury. Cell Death Discov, 2023 Aug 25. PMID: 37626060

¡¾ÌâÄ¿¡¿

ÖÐÐÔÁ£Ï¸°û°ûÍâÏÝÚåͨ¹ýŧ¶¾Ö¢Ïà¹Ø·ÎËðÉËÖÐµÄ STING ;¾¶´Ù½øÃâÒßѪ˨ÐγÉ

¡¾Í¨Ñ¶×÷Õß¡¿

¹ù¿Ë·¼  ¸´µ©´óѧ¸½ÊôÖÐɽҽԺÂé×í¿Æ£¬ÉϺ£ÊÐΧÊÖÊõÆÚÓ¦¼¤Óë±£»¤ÖصãʵÑéÊÒ£»

¡¾µÚÒ»×÷Õß¡¿

Shuai-Nan Zhu  ¸´µ©´óѧ¸½ÊôÖÐɽҽԺÂé×í¿Æ£¬ÉϺ£ÊÐΧÊÖÊõÆÚÓ¦¼¤Óë±£»¤ÖصãʵÑéÊÒ£»

¡¾ÕªÒª¡¿

ÖÐÐÔÁ£Ï¸°ûϸ°ûÍâÏÝÚ壨NET£©²ÎÓë¶à¸öÖØµþºÍÏ໥×÷ÓõÄÐźÅͨ·£¨¶ÔËðÉË¡¢Ñ×Ö¢ºÍÄýѪµÄÃâÒß·´Ó¦£©µÄ¼¤»îºÍ¹¦ÄÜʧµ÷£¬ÕâЩͨ·½éµ¼Å§¶¾Ö¢Òý·¢µÄ¼±ÐÔ·ÎËðÉË£¨SI-ALI£©¡£È»¶ø£¬NETsÈçºÎ½éµ¼Ñ×Ö¢ºÍÄýѪ֮¼äµÄ¹ØÁªÉÐδÍêÈ«²ûÃ÷¡£ÔÚ´ËÎÒÃÇ·¢ÏÖ£¬Í¨¹ý¸ÉÈÅËØ»ùÒò´Ì¼¤¼Á£¨STING£©¼¤»îµÄNETsÓÕµ¼ÄÚÆ¤Ï¸°ûËðÉË£¬²¢²úÉú´óÁ¿µÄ×éÖ¯Òò×Ó£¨TF£©£¬´Ó¶ø·Å´óÁËÑ×Ö¢ºÍÄýѪ·´Ó¦Ö®¼äµÄʧµ÷£¬µ¼ÖÂSI-ALIÄ£ÐÍСÊóÔ¤ºó²»Á¼¡£ÆÆ»µNETºÍÒÖÖÆSTING¿ÉÒÔ¸ÄÉÆ°ÜѪ֢СÊóµÄÔ¤ºó£¬²¢¼õÉÙÁËÑ×Ö¢·´Ó¦ºÍÄýѪ¡£´ËÍ⣬ÄÚÆ¤Ï¸°û±íÃæµÄTollÑùÊÜÌå-2£¨TLR2£©²ÎÓëÁËNETsÓëSTINGͨ·֮¼äµÄÏ໥×÷Óá£×ÛÉÏËùÊö£¬ÔÚSI-ALIµÄÐγɹý³ÌÖУ¬NETsÒÔSTINGÒÀÀµµÄ·½Ê½¼¤»îÄÚÆ¤Ï¸°ûÖеÄÄýѪ·´Ó¦¡£


23. Jia-Ling Wang#, Ting Lu#, Ya-Li Gui, Xiao-Jin Zhang, Xiao-Fei Cao, Yue-Hua Li, Chuan-Fu Li, Li Liu, Zheng-Nian Ding*. HSPA12A controls cerebral lactate homeostasis to maintain hippocampal neurogenesis and mood stabilization. Transl Psychiatry, 2023 Aug 14. PMID: 37580315

¡¾ÌâÄ¿¡¿

HSPA12Aͨ¹ý¿ØÖÆ´óÄÔÈéËáÎÈ̬ά³Öº£ÂíÉñ¾­·¢ÉúºÍÇéÐ÷Îȶ¨

¡¾Í¨Ñ¶×÷Õß¡¿

¶¡ÕýÄê  ÄϾ©Ò½¿Æ´óѧµÚÒ»¸½ÊôÒ½ÔºÂé×í¿Æ

¡¾µÚÒ»×÷Õß¡¿

Jia-Ling Wang  ÄϾ©Ò½¿Æ´óѧµÚÒ»¸½ÊôÒ½ÔºÂé×í¿Æ£¬ÄϾ©Ò½¿Æ´óѧµÚÒ»¸½ÊôÒ½ÔºÀÏÄ겡¿Æ£¬½­ËÕÊ¡ÀÏÄêÒ½Ñ§ÖØµãʵÑéÊÒ£»
³æÃ  ÄϾ©Ò½¿Æ´óѧµÚÒ»¸½ÊôÒ½ÔºÂé×í¿Æ£»

¡¾ÕªÒª¡¿

ÇéÐ÷²»Îȶ¨ÊÇÒ»ÖÖÖ÷¹ÛÇéÐ÷״̬£¬¶¨ÒåΪÇéÐ÷¿ìËÙ²¨¶¯£¬ÊǶàÖÖ¾«Éñ¼²²¡£¬ÌرðÊÇÔÚÖØ¶ÈÒÖÓôÖ¢ºÍË«ÏàÇé¸ÐÕϰ­ÖгöÏÖµÄÖ¢×´¡£ÈÈÐݿ˵°°×A12A£¨HSPA12A£©ÔÚ¾«Éñ·ÖÁÑÖ¢»¼Õß´óÄÔÖеıí´ï¼õÉÙ£¬È»¶øÆäÔÚÈκξ«Éñ¼²²¡ÖеÄЧӦÍêȫδ֪¡£ÎªÁËÑо¿HSPA12AÊÇ·ñÓ°ÏìÇéÐ÷Îȶ¨ÐÔ£¬¶ÔHspa12a»ùÒòÇóýСÊó£¨Hspa12a−/−£©ºÍÒ°ÉúÐÍ£¨WT£©Í¬ÎÑСÊó½øÐÐÁË¿õ³¡ÊÔÑ顢ǿÆÈÓÎÓ¾¡¢¸ß¼ÜÊ®×ÖÃÔ¹¬ºÍÕáÌÇÆ«ºÃµÄ²âÊÔ¡£²âÁ¿ÄÔ¼¹Òº£¨CSF£©ÖеÄÈéËáˮƽ¡£Í¨¹ýBrdU±ê¼ÇÆÀ¹À³ÉÈ˺£ÂíÉñ¾­·¢Éú£¨AHN£©¡£ÎÒÃÇ·¢ÏÖ¼±ÐÔÇéÐ÷ѹÁ¦»áÔö¼ÓСÊóº£ÂíHSPA12AµÄ±í´ïºÍÄÔ¼¹ÒºÈéËáˮƽ¡£È»¶ø£¬Hspa12a−/−СÊó±íÏÖ³öÇéÐ÷²»Îȶ¨µÄÐÐΪ£¨¿ì¸Ðȱ·¦£¬Ô˶¯»îÐÔ½µµÍ£¬¿¹ÒÖÓôºÍ½¹ÂÇ£©£¬²¢°éÓÐAHNÊÜËð£¬ÄÔ¼¹ÒºÈéËáˮƽ½µµÍºÍº£ÂíÌǽͽâø±í´ïϵ÷¡£Ïà±È֮ϣ¬HSPA12A¹ý±í´ïÔö¼ÓÁËÔ­´úº£ÂíÉñ¾­ÔªµÄÈéËá²úÉúºÍÌǽͽâø±í´ï¡£ÓÐȤµÄÊÇ£¬¸øÓèÈéËá¼õÇáÁËHspa12a−/−СÊóµÄÇéÐ÷²»Îȶ¨ºÍAHNËðÉË¡£½øÒ»²½·ÖÎö±íÃ÷£¬HSPA12AÊÇά³Ö´óÄÔÈéËáÎÈ̬Ëù±ØÐèµÄ£¬Õâ¿ÉÒÔͨ¹ýÒÖÖÆº£ÂíÉñ¾­ÔªÖеÄGSK3¦ÂÀ´½éµ¼£¬´Ó¶øÎ¬³ÖAHNºÍÇéÐ÷Îȶ¨¡£×ÛÉÏËùÊö£¬HSPA12A±»¶¨ÒåΪһÖÖÐÂÐ͵ÄÇéÐ÷Îȶ¨ÐÔµ÷½Ú¼Á£¬²¢¾ßÓÐÖÎÁÆÇéÐ÷Õϰ­µÄDZÁ¦¡£ÎÒÃǵÄÑо¿½á¹û½¨Á¢ÁËÒ»¸ö¿ò¼Ü£¬ÓÃÓÚÈ·¶¨ÇéÐ÷Õϰ­ºÍAHNÓë´óÄÔÈéËáÎÈ̬µÄÏà¹ØÐÔ¡£


24. Li-Jing Yang#, Sheng Shi, Jun Li, Zhong-Rong Fang, Jing-Fei Guo, Wen-Ying Kang, Jia Shi, Su Yuan, Fu-Xia Yan, Cheng-Hui Zhou*. Postoperative elevated cardiac troponin levels predict all-cause mortality and major adverse cardiovascular events following noncardiac surgery: A dose-response meta-analysis of prospective studies J Clin Anesth, 2023 Aug 11. PMID: 37573706

¡¾ÌâÄ¿¡¿

ÊõºóÐ¡¸Æµ°°×ˮƽÉý¸ß¿ÉÔ¤²â·ÇÐÄÔàÊÖÊõºóµÄÈ«ÒòËÀÍöÂʺÍÖ÷Òª²»Á¼ÐÄѪ¹Üʼþ£º¶ÔǰհÐÔÑо¿µÄ¼ÁÁ¿·´Ó¦ÜöÝÍ·ÖÎö


¡¾Í¨Ñ¶×÷Õß¡¿

Ö̻ܳԠ Ê×¶¼Ò½¿Æ´óѧ¸½Êô±±¾©°²ÕêÒ½ÔºÂé×íÖÐÐÄ£¬Öйúҽѧ¿ÆÑ§Ôº-±±¾©Ð­ºÍҽѧԺ¹ú¼ÒÐÄѪ¹Ü¼²²¡ÖÐÐĸ·ÍâÒ½ÔºÂé×í¿Æ£¬ÐÄѪ¹Ü¼²²¡¹ú¼ÒÖØµãʵÑéÊÒ£»

¡¾µÚÒ»×÷Õß¡¿

Li-Jing Yang  Öйúҽѧ¿ÆÑ§Ôº-±±¾©Ð­ºÍҽѧԺ¹ú¼ÒÐÄѪ¹Ü¼²²¡ÖÐÐĸ·ÍâÒ½ÔºÂé×í¿Æ£¬ÐÄѪ¹Ü¼²²¡¹ú¼ÒÖØµãʵÑéÊÒ£»

¡¾ÕªÒª¡¿

Ñо¿Ä¿µÄ£º¶Ô·ÇÐÄÔàÊÖÊõÊõºóÐļ¡ËðÉË£¨PMI£©ÓëÈ«ÒòËÀÍöÂÊ»òÖ÷Òª²»Á¼ÐÄѪ¹Üʼþ£¨MACE£©·çÏÕÖ®¼äµÄ¹ØÁª½øÐмÁÁ¿·´Ó¦ÜöÝÍ·ÖÎö¡£


Éè¼Æ£ºÊ¹ÓüÓȨ£¨WL£©»ò¹ãÒ壨GL£©ÏßÐÔºÍÏÞÖÆÈý´ÎÑùÌõ£¨RCS£©»Ø¹é¶ÔǰհÐÔÑо¿½øÐмÁÁ¿·´Ó¦ÜöÝÍ·ÖÎö¡£


µØµã£º½ÌѧҽԺ¡£


²¡ÈË£º½ÓÊÜ·ÇÐÄÔàÊÖÊõµÄ³ÉÄ껼Õß¡£


¸ÉÔ¤£ºÎÞ¡£


²âÁ¿£ºÖ÷Òª½á¾ÖÊÇÈ«ÒòËÀÍöÂÊ¡£´ÎÒª½á¾ÖÊÇMACE¡£


Ö÷Òª½á¹û£ºÄÉÈë29ÏîÑо¿£¨53518Ãû»¼Õߣ©¡£PMIµÄ×ÜÌå·¢ÉúÂÊΪ26.0%£¨95% CI 21.0%ÖÁ32.0%£©¡£ÓëÎÞPMIµÄ»¼ÕßÏà±È£¬PMI»¼Õß¶ÌÆÚ£¨£¼12¸öÔ£©Ëæ·Ã£¨Ð¡¸Æµ°°×[cTn]I£ºunadj OR 1.71£¬95%CI 1.22ÖÁ2.41£¬P£¼0.001£»cTnT£ºunadj OR 2.33£¬95%CI 2.07ÖÁ2.63£¬P£¼0.001)ºÍ³¤ÆÚ£¨¡Ý12¸öÔ£©Ëæ·Ã£¨cTnI£ºunadj OR 1.80£¬95%CI 1.63ÖÁ1.99£»cTnT£ºunadj OR 1.47£¬95%CI 1.33ÖÁ1.62£©£¨ËùÓÐP£¼0.001£©µÄÈ«ÒòËÀÍö·çÏÕÔö¼Ó¡£¶ÔÓÚMACE£¬ÖµÉý¸ßµÄ×éÓë·çÏÕÔö¼ÓÏà¹Ø£¨cTnI£ºunadj OR 1.98£¬95% CI 1.13 ÖÁ 3.47£¬P=0.018£»cTnT£ºunadj OR 2.29£¬95% CI 1.88ÖÁ2.79£¬P£¼0.001£©¡£¼ÁÁ¿·´Ó¦·ÖÎöÏÔʾPMI£¨Ã¿1¡Á²Î¿¼ÉÏÏÞhttps://mp.weixin.qq.com/s?__biz ... ËΧÊõÆÚѪѹ¹ÜÀí²ßÂÔÖé½­ÊÓ½ç | ÇñÓôÞ±½ÌÊÚ£º·Ç²å¹ÜÐØ¿ÆÊÖÊõµÄÂé×í
Öé½­ÊÓ½ç | ÿÔºÃÎÄ£º¹úÄÚÂé×íѧ¿ÆÎÄÕª2023.09£¨ÉÏ£©
Öé½­ÊÓ½ç | ÿÔºÃÎÄ£º¹úÄÚÂé×íѧ¿ÆÎÄÕª2023.08£¨ÉÏ£©
Öé½­ÊÓ½ç | ÿÔºÃÎÄ£º¹úÄÚÂé×íѧ¿ÆÎÄÕª2023.08£¨Ï£©
Öé½­ÊÓ½ç | Õž§½ÌÊÚ£ºÖØÖ¢ÐÄÂÉʧ³£»¼Õß·ÇÐÄÔàÊÖÊõÂé×í¹ÜÀí£«²¡Àý

ÉùÃ÷
±¾Î¢ÐŹ«ÖÚºÅËù¿¯ÔØÔ­´´»ò×ªÔØÄÚÈݲ»´ú±íÐÂÇàÄêÂé×íÂÛ̳¹Ûµã»òÁ¢³¡¡£ÎÄÖÐËùÉæ¼°Ò©ÎïʹÓᢼ²²¡ÕïÁƵÈÄÚÈݽö¹©²Î¿¼¡£


Â¥Ö÷ÈÈÌû

ÂíÉÏ×¢²á£¬ÏíÓøü¶à¹¦ÄÜ£¬ÈÃÄãÇáËÉÍæ×ªÂÛ̳

ÄúÐèÒª µÇ¼ ²Å¿ÉÒÔÏÂÔØ»ò²é¿´£¬Ã»ÓÐÕʺţ¿»áÔ±×¢²á

x

ÓÑÇéÌáʾ£º×ªÔØÇë×¢Òâ×¢Ã÷×÷Õߺͳö´¦£¡£¡

ÄúÐèÒªµÇ¼ºó²Å¿ÉÒÔ»ØÌû µÇ¼ | »áÔ±×¢²á

±¾°æ»ý·Ö¹æÔò

ÊÕ²ØÌû×Ó ·µ»ØÁбí ÁªÏµÎÒÃÇ ËÑË÷ ¹Ù·½QQȺ

QQ|¹ØÓÚÎÒÃÇ|ÒµÎñºÏ×÷|ÊÖ»ú°æ|ÐÂÇàÄêÂé×íÂÛ̳ ( ÕãICP±¸19050841ºÅ-1 )

GMT+8, 2025-12-15 06:33 , Processed in 0.137059 second(s), 23 queries , Gzip On.

Powered by Discuz! X3.2

© 2001-2013 Comsenz Inc.

¿ìËٻظ´ ·µ»Ø¶¥²¿ ·µ»ØÁбí